HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis.

Abstract
HIPK2 is a stress-induced kinase and a transcriptional corepressor that functionally cooperates with p53 to suppress cancer. Activation of the p53 proapoptotic function requires a cascade of phosphorylations and acetylations, and HIPK2 takes part in both modifications in that it phosphorylates p53 Ser46 and induces p53 Lys382 acetylation. Here, to further investigate the role of HIPK2 in p53 activation, we started with the finding that HIPK2 inhibition upregulated Nox1, a homolog of the catalytic subunit of the superoxide-generating NADPH oxidase, involved in tumor progression and ROS production. We found that Nox1 inhibited p53 Lys382 acetylation, which is a target of SIRT1 deacetylase, and impaired p53 proapoptotic transcriptional activity. By the use of either small interfering RNAs to target SIRT1 or the SIRT1 inhibitor nicotinamide we found that Nox1-dependent inhibition of p53 transcriptional activity was SIRT1-dependent. Thus, Nox1 was unable to inhibit p53 when coexpressed with a SIRT1 deacetylase-defective mutant (SIRT1HY), suggesting a link between Nox1 and SIRT1 activity. Finally, recovery of HIPK2 function downregulated Nox1 expression with rescue of p53 Lys382 acetylation and p53 activity. Together, our findings indicate that Nox1 upregulation may activate SIRT1 and inhibit p53 and that Lys382 is important for p53 proapoptotic function.
AuthorsRosa Puca, Lavinia Nardinocchi, Giuseppe Starace, Gideon Rechavi, Ada Sacchi, David Givol, Gabriella D'Orazi
JournalFree radical biology & medicine (Free Radic Biol Med) Vol. 48 Issue 10 Pg. 1338-46 (May 15 2010) ISSN: 1873-4596 [Electronic] United States
PMID20171273 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Carrier Proteins
  • Mutant Proteins
  • RNA, Small Interfering
  • Tumor Suppressor Protein p53
  • Niacinamide
  • NADPH Oxidase 1
  • NADPH Oxidases
  • NOX1 protein, human
  • HIPK2 protein, human
  • Protein Serine-Threonine Kinases
  • SIRT1 protein, human
  • Sirtuin 1
Topics
  • Acetylation (drug effects)
  • Apoptosis (drug effects, genetics)
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Carcinoma (genetics, metabolism, pathology)
  • Carrier Proteins (biosynthesis, genetics)
  • Cell Line, Tumor
  • Cloning, Molecular
  • Colonic Neoplasms (genetics, metabolism, pathology)
  • Female
  • Humans
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Mutant Proteins (genetics, metabolism)
  • NADPH Oxidase 1
  • NADPH Oxidases (biosynthesis, genetics)
  • Niacinamide (pharmacology)
  • Protein Serine-Threonine Kinases (biosynthesis, genetics)
  • RNA, Small Interfering (genetics)
  • Sirtuin 1 (antagonists & inhibitors, genetics, metabolism)
  • Transcriptional Activation (drug effects, genetics)
  • Tumor Suppressor Protein p53 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: